Loading...

NRVG

NGN

NERVGEN PHARMA CORP

(NGEN)

2026 6-K

6-K Filing Summary

15 May '26

CFO Appointment

27 Apr '26

Delisting Announcement

13 Mar '26

Management Change

13 Feb '26

CEO Appointment

10 Feb '26

External Links:

SEC

On February 12, 2026, NervGen Pharma Corp. announced the resignation of CFO William J. Adams, effective March 15, 2026, and appointed Dr. Adam Rogers as interim CFO.

AI Assistant

NERVGEN PHARMA CORP

2026

6 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.